Literature DB >> 3368191

Neuroblastoma: incomplete differentiation on the way to maturation or morphological alteration resembling maturity?

S Ogita1, K Tokiwa, N Arizono, T Takahashi.   

Abstract

The following study was performed to investigate whether antitumor agents can induce maturation of advanced neuroblastoma (NB). Of 56 NB patients (1970-1987), 13 in stage III or IV underwent resection of the primary tumor (11 abdominal, 2 mediastinal) following complete or partial response to preoperative chemotherapy (11 conventional cytotoxic chemotherapy, 2 conventional cytotoxic chemotherapy combined with intraarterial infusion of prostaglandin E1 and oral papaverine). Histological examinations, performed on these 13 NB patients before and after chemotherapy, showed (1) differentiation of the NB to ganglioneuroblastoma (GNB) with predominance of mature atypical ganglion cells, development of stromal components and a few immature malignant cells in 10 of 13 and (2) differentiation of the NB to a more mature form than was seen histologically before treatment in the remaining 3. Our results indicate that the morphological differentiation of immature NB in advanced stage to more mature GNB can be induced by conventional cytotoxic chemotherapy with or without so-called 'maturation-inducing' agents. However, the chemotherapy-induced morphological differentiation did not correlate with the prognosis of the patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3368191     DOI: 10.1159/000226552

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  5 in total

1.  p75NTR: an enhancer of fenretinide toxicity in neuroblastoma.

Authors:  Veena Ganeshan; John Ashton; Nina F Schor
Journal:  Cancer Chemother Pharmacol       Date:  2013-01-13       Impact factor: 3.333

2.  Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation.

Authors:  S E Bates; L A Mickley; Y N Chen; N Richert; J Rudick; J L Biedler; A T Fojo
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 5.069

3.  Morphologic alteration of metastatic neuroblastic tumor in bone marrow after chemotherapy.

Authors:  Go Eun Bae; Yeon-Lim Suh; Ki Woong Sung; Jung-Sun Kim
Journal:  Korean J Pathol       Date:  2013-10-25

4.  Presence of differentiating neuroblasts in bone marrow is a favorable prognostic factor for bone marrow metastatic neuroblastoma at diagnosis.

Authors:  Sang Hyuk Park; Sollip Kim; Chan-Jeoung Park; Seongsoo Jang; Hyun-Sook Chi; Kyung-Nam Koh; Ho Joon Im; Jong Jin Seo
Journal:  Ann Lab Med       Date:  2013-02-21       Impact factor: 3.464

5.  PPARgamma in Neuroblastoma.

Authors:  Alessandro Peri; Ilaria Cellai; Susanna Benvenuti; Paola Luciani; Silvana Baglioni; Mario Serio
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.